- Review
“Omics”-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives
- Holly Matthews,
- James Hanison and
- Niroshini Nirmalan
The pharmaceutical industry faces unsustainable program failure despite significant increases in investment. Dwindling discovery pipelines, rapidly expanding R&D budgets and increasing regulatory control, predict significant gaps in the future dr...

